Prognostic factors in a multicenter study for treatment of acute lymphoblastic leukemia in adults

Hoelzer, D.; Thiel, E.; Löffler, H.; Büchner, Th.; Ganser, Arnold; Heil, Gerhard; Koch, P.; Freund, Mathias; Diedrich, H.; Rühl, Heiko

doi:10.1182/blood.v71.1.123.123

Public

Prognostic factors in a multicenter study for treatment of acute lymphoblastic leukemia in adults

Published in Blood • Jan 1, 1988

Authors:

D. Hoelzer

E. Thiel

H. Löffler

Abstract

In a prospective multicenter study, 368 acute lymphoblastic leukemia (ALL) patients aged 15 to 65 years were treated with an intensified induction and reinduction regimen; 272 (73.9%) achieved complete remission (CR). The median remission duration (MRD) is 24.3 months, and the probability of being i...

Subject

Medicine

Internal medicine

Hepatosplenomegaly

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!